Bio-Techne Corp
TECHHealthcare·Biotechnology·USA·Large·NASD·Nov 13 • 8:01 AM ET
73.00+0.16 (0.22%)
2026-11-13 14:08 CET
Market cap
$11.47B
Revenue, TTM
1,228.19 USD m
Net income, TTM
171.97 USD m
Free cash flow, TTM
308.20 USD m
EPS diluted, TTM
1.09
66.76
Price
TECH against its 20, 50 and 200-day averagesPatternshover a marker to name it
0.7% under the 52-week high of 73.50 on 13 Nov 2026. 52-week low 43.20 on 15 May 2026. Last 15 sessions, 1.3% high to low
Volume 0.07× normal · the line is the 50-bar volume average
Setup. RS line 51
CANSLIM 3 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); Performance: Year +50%
VCP 5 of 6 — fails: RSI (14): Not Overbought (<60)
Minervini 3 of 4 — fails: Performance: Year +50%
Zanger 3 of 5 — fails: Performance: Week +10%; Relative Volume: Over 1.5
Leaders 4 of 5 — fails: Performance: Year +50%
Breakout 3 of 4 — fails: Relative Volume: Over 2
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: P/E: Under 15; P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 0 of 4 — fails: Dividend Yield: Over 2%; Dividend Growth: Growing 2+ Years; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: Float: Under 100M; Performance: Year +50%
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%
Profile
TECH52-week range, 98% of the way up
43.2073.50
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
| Index | S&P 500, RUI |
|---|---|
| Employees | 3000 |
| IPO | Feb 09, 1989 |
| Beta | 1.27 |
| ATR, 14d | 0.17 |
| Rel volume | 0.07 |
| Short float | 4.93% |
| Insider own | 0.55% |
| Inst own | 106.81% |
Snapshot
6 groupsValuation
| Index | S&P 500, RUI |
|---|---|
| Market Cap | $11.47B |
| Enterprise Value | 11.40B |
| Income | 171.97M |
| Sales | 1.23B |
| Book / share | 13.79 |
| Cash / share | 2.23 |
| Dividend Est. | 0.32 (0.44%) |
| Dividend TTM | 0.32 (0.44%) |
| Dividend Ex-Date | Nov 13, 2026 |
| Dividend Gr. 3/5Y | 0.00% 0.00% |
| Payout | 27.63% |
| Employees | 3000 |
| IPO | Feb 09, 1989 |
Ratios
| Price / earnings | 66.76 |
|---|---|
| Forward price / earnings | 30.93 |
| Price / earnings / growth | 3.74 |
| Price / sales | 9.34 |
| Price / book | 5.29 |
| Price / cash | 32.76 |
| Price / free cash flow | 37.21 |
| Value / cash profit | 31.79 |
| Value / sales | 9.28 |
| Quick Ratio | 1.74 |
| Current Ratio | 2.28 |
| Debt / equity | 0.13 |
| Long-term debt / equity | 0.03 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | 1.09 |
|---|---|
| Earnings next year | 2.36 |
| Earnings next quarter | 0.47 |
| Earnings this year | 6.37% |
| Earnings next year | 14.96% |
| Earnings growth, 5 years | 8.28% |
| Past earnings growth | -13.05% 5.97% |
| Past sales growth | 2.25% 5.47% |
| Earnings vs last year | 122.38% |
| Sales vs last year | 0.94% |
| Earnings vs last quarter | -26.66% |
| Sales vs last quarter | 4.59% |
| Earnings | Nov 06 AMC |
| Surprise | 0.00% 2.43% |
Ownership
| Insiders own | 0.55% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 106.81% |
| Institution trades | -4.53% |
| Return on assets | 6.66% |
| Return on equity | 8.32% |
| Return on capital | 7.69% |
| Gross Margin | 65.96% |
| Operating margin | 21.32% |
| Profit Margin | 14.00% |
| 20-day average | 0.41% |
| 50-day average | 0.64% |
| 200-day average | 15.18% |
Technical
| Shares out | 157.05M |
|---|---|
| Shares floating | 156.22M |
| Short / float | 4.93% |
| Short ratio | 2.74 |
| Short interest | 7.70M |
| 52-week high | 73.50 -0.7% |
| 52-week low | 43.20 +69.0% |
| Volatility | 0.15% 0.16% |
| Average range | 0.17 |
| Strength index | 69.12 |
| Market sensitivity | 1.27 |
| Relative volume | 0.07 |
| Avg Volume | 2.81M |
| Volume | 9,823 |
Performance
| Perf Week | 0.30% |
|---|---|
| Perf Month | 0.66% |
| Perf Quarter | 0.84% |
| Perf Half Y | 68.59% |
| Perf YTD | 24.13% |
| Perf Year | 20.16% |
| Perf 3Y | 27.85% |
| Perf 5Y | -42.12% |
| Perf 10Y | 174.20% |
| Recommendation | 3.18 |
| Target Price | 73.29 |
| Prev Close | 72.84 |
| Price | 73.00 |
| Change % | 0.22% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Aug 13, 2026 | Downgrade | Wells Fargo | Overweight → Equal Weight | $73 | 0.0% |
| Jun 11, 2026 | Initiated | Piper Sandler | Neutral | $65 | -11.0% |
| May 15, 2026 | Resumed | RBC Capital Mkts | Outperform | $62 | -15.1% |
| Sep 03, 2025 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform | $73 | 0.0% |
| Aug 21, 2025 | Upgrade | Citigroup | Neutral → Buy | $70 | -4.1% |
| Jul 22, 2025 | Resumed | Stephens | Overweight | $65 | -11.0% |
| Jul 09, 2025 | Initiated | TD Cowen | Buy | $65 | -11.0% |
| May 30, 2025 | Initiated | Wells Fargo | Overweight | $59 | -19.2% |
| Apr 09, 2025 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight | ||
| Mar 18, 2025 | Initiated | Evercore ISI | Outperform | $75 | +2.7% |
Peers
Mkt capInsider trading
latest 14 of 26| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Hippel James | CFO | Nov 01 '26 | Option Exercise | 0.00 | 11,545 | 0 | 181,816 | Nov 03 04:21 PM |
| HIGGINS JOHN L | Director | Sep 28 '26 | Option Exercise | 0.00 | 15,940 | 0 | 82,816 | Sep 30 04:13 PM |
| BAUMGARTNER ROBERT V | Director | Sep 22 '26 | Option Exercise | 0.00 | 15,940 | 0 | 62,443 | Sep 24 04:52 PM |
| Kelderman Kim | Chief Executive Officer | Aug 15 '26 | Option Exercise | 0.00 | 21,470 | 0 | 93,583 | Aug 18 05:14 PM |
| Hippel James | CFO | Aug 15 '26 | Option Exercise | 0.00 | 9,779 | 0 | 174,493 | Aug 18 05:13 PM |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15 '26 | Option Exercise | 0.00 | 6,416 | 0 | 26,919 | Aug 18 05:13 PM |
| Bohnen Shane | SVP - General Counsel | Aug 15 '26 | Option Exercise | 0.00 | 4,350 | 0 | 11,703 | Aug 18 04:42 PM |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 15 '26 | Option Exercise | 0.00 | 5,423 | 0 | 12,184 | Aug 18 04:13 PM |
| Herr Amy E. | Director | Aug 15 '26 | Option Exercise | 0.00 | 589 | 0 | 789 | Aug 18 04:12 PM |
| Hippel James | CFO | Jul 29 '26 | Option Exercise | 47.60 | 62,068 | 2,954,437 | 215,738 | Jul 31 05:18 PM |
| Kelderman Kim | Chief Executive Officer | Jul 28 '26 | Option Exercise | 47.60 | 35,000 | 1,666,000 | 100,799 | Jul 30 04:11 PM |
| Bohnen Shane | SVP - General Counsel | Jul 23 '26 | Option Exercise | 47.60 | 448 | 21,325 | 7,697 | Jul 27 04:03 PM |
| Herr Amy E. | Director | May 08 '26 | Option Exercise | 47.60 | 6,636 | 315,874 | 6,836 | May 12 04:04 PM |
| Herr Amy E. | Director | May 08 '26 | Sale | 48.28 | 6,636 | 320,386 | 200 | May 12 04:04 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| VOO | Vanguard S&P 500 ETF | AUM: 1070.75B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| RSP | Invesco S&P 500 Equal Weight ETF | AUM: 105.70B |
| SEQ | Sequoia ETF | AUM: 7.07B |
| IVV | iShares Core S&P 500 ETF | AUM: 882.14B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.68B |
| SPY | SPDR S&P 500 ETF Trust | AUM: 805.69B |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | AUM: 3.07B |
| IBB | iShares Biotechnology ETF | AUM: 11.39B |
News
latest 14 of 200- BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
- Stocks rebound as oil prices sink, Anthropic releases Q3 financials: AlphaCheck (Yahoo Finance)
- Alphabet tumbles, software and cybersecurity stocks sink as earnings disappoint: AlphaCheck (Yahoo Finance)
- Bio-Techne opens GMP small molecule facility in Bristol, UK (Pharmaceutical Business Review)
- Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development (PR Newswire)
- Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany (PR Newswire)
- Bio-Techne Opens New Customer Experience Center in Dusseldorf to Accelerate Scientific Discovery and Customer Collaboration (PR Newswire)
- Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders? (PR Newswire)
- Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals (PR Newswire)
- Are PAYO, TECH, CBAN Obtaining Fair Deals for their Shareholders? (PR Newswire)
- Bio-Techne Corrects Dividend Announcement (PR Newswire)
- Bio-Techne Releases Fourth Quarter Fiscal 2026 Results (PR Newswire)
- Bio-Techne Declares Dividend (PR Newswire)
- Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio (PR Newswire)
Quarterly earnings
2027Q1 EPS 0.440 matched 0.440, from 0.420 a year earlier. Sales 299.71 beat 292.6, from 286.56 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2027Q1ended 2026-09-30 | 2026-11-06 16:30 | 0.440 | 0.440 | 0.180 | 299.71 | 292.6 | EPS 0.0% · sales +2.4% | vs 2026Q1, year-ago quarter · EPS +4.8% · sales +4.6% | 4 EPS · 3 sales | Open +0.07% vs SPY +0.91%. Close +0.07% vs SPY +2.37% |
| 2026Q4ended 2026-06-30 | 2026-08-12 08:30 | 0.520 | 0.519 | 0.350 | 321.19 | 314.63 | EPS +0.1% · sales +2.1% | vs 2025Q4, year-ago quarter · EPS -1.9% · sales +1.3% | 12 | Open -0.04% vs SPY +0.54%. Close +0.11% vs SPY +0.25% |
| 2026Q3ended 2026-03-31 | 2026-05-06 08:30 | 0.530 | 0.534 | 0.324 | 311.42 | 316.11 | EPS -0.8% · sales -1.5% | vs 2025Q3, year-ago quarter · EPS -5.4% · sales -1.5% | 12 | Open 0.00% vs SPY +0.61%. Close -16.36% vs SPY +1.39% |
| 2026Q2ended 2025-12-31 | 2026-02-04 08:30 | 0.460 | 0.434 | 0.242 | 295.88 | 290.47 | EPS +6.0% · sales +1.9% | vs 2025Q2, year-ago quarter · EPS +9.5% · sales -0.4% | 14 | Open +3.19% vs SPY +0.12%. Close +6.25% vs SPY -0.48% |
| 2026Q1ended 2025-09-30 | 2025-11-05 08:30 | 0.420 | 0.421 | 0.244 | 286.56 | 291.32 | EPS -0.3% · sales -1.6% | vs 2025Q1, year-ago quarter · EPS 0.0% · sales -1.0% | 14 | Open -10.97% vs SPY -0.04%. Close -1.90% vs SPY +0.35% |
| 2025Q4ended 2025-06-30 | 2025-08-06 08:30 | 0.530 | 0.499 | -0.114 | 316.96 | 314.61 | EPS +6.1% · sales +0.7% | vs 2024Q4, year-ago quarter · EPS +8.2% · sales +3.5% | 16 | Open -2.71% vs SPY +0.17%. Close -8.73% vs SPY +0.77% |
| 2025Q3ended 2025-03-31 | 2025-05-07 08:30 | 0.560 | 0.508 | 0.142 | 316.18 | 317.19 | EPS +10.3% · sales -0.3% | vs 2024Q3, year-ago quarter · EPS +16.7% · sales +4.2% | 13 | Open +4.76% vs SPY +0.24%. Close +2.16% vs SPY +0.42% |
| 2025Q2ended 2024-12-31 | 2025-02-05 08:30 | 0.420 | 0.386 | 0.217 | 297.03 | 285.78 | EPS +8.8% · sales +3.9% | vs 2024Q2, year-ago quarter · EPS +5.0% · sales +9.0% | 13 | Open +9.28% vs SPY -0.19%. Close +3.72% vs SPY +0.41% |
| 2025Q1ended 2024-09-30 | 2024-10-30 08:30 | 0.420 | 0.382 | 0.209 | 289.46 | 280.22 | EPS +10.1% · sales +3.3% | vs 2024Q1, year-ago quarter · EPS +2.4% · sales +4.5% | 13 | Open +4.61% vs SPY -0.08%. Close +7.46% vs SPY -0.30% |
| 2024Q4ended 2024-06-30 | 2024-08-07 08:30 | 0.490 | 0.495 | 0.253 | 306.1 | 306.49 | EPS -1.0% · sales -0.1% | vs 2023Q4, year-ago quarter · EPS -10.9% · sales +1.6% | 13 | Open -1.15% vs SPY +1.21%. Close -9.51% vs SPY -0.67% |
| 2024Q3ended 2024-03-31 | 2024-05-01 08:30 | 0.480 | 0.453 | 0.306 | 303.43 | 292.15 | EPS +6.0% · sales +3.9% | vs 2023Q3, year-ago quarter · EPS -9.4% · sales +3.2% | 12 | Open +11.60% vs SPY -0.12%. Close +16.22% vs SPY -0.32% |
| 2024Q2ended 2023-12-31 | 2024-02-01 08:30 | 0.400 | 0.412 | 0.172 | 272.6 | 277.55 | EPS -3.0% · sales -1.8% | vs 2023Q2, year-ago quarter · EPS -14.9% · sales +0.4% | 12 | Open -4.58% vs SPY +0.36%. Close -2.53% vs SPY +1.31% |
| 2024Q1ended 2023-09-30 | 2023-10-31 08:30 | 0.410 | 0.435 | 0.315 | 276.94 | 287.66 | EPS -5.7% · sales -3.7% | vs 2023Q1, year-ago quarter · EPS -7.9% · sales +2.7% | 12 EPS · 11 sales | - |
| 2023Q4ended 2023-06-30 | 2023-08-08 08:30 | 0.550 | 0.547 | 0.466 | 301.32 | 307.22 | EPS +0.6% · sales -1.9% | vs 2022Q4, year-ago quarter · EPS +7.3% · sales +4.5% | 12 EPS · 11 sales | - |
| 2023Q3ended 2023-03-31 | 2023-05-03 08:30 | 0.530 | 0.528 | 0.434 | 294.15 | 296.61 | EPS +0.4% · sales -0.8% | vs 2022Q3, year-ago quarter · EPS -0.9% · sales +1.3% | 12 EPS · 11 sales | - |
| 2023Q2ended 2022-12-31 | 2023-02-02 08:30 | 0.470 | 0.488 | 0.309 | 271.58 | 288.8 | EPS -3.7% · sales -6.0% | vs 2022Q2, year-ago quarter · EPS 0.0% · sales +0.9% | 12 EPS · 11 sales | - |
Annual earnings
2026FY EPS 1.930 beat 1.923, from 1.920 a year earlier. Sales 1,215 beat 1,207, from 1,220 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 2.690 | - | - | 1,718 | 27.14 |
| 2029FYestimate | - | 2.450 | - | - | 1,575 | 29.80 |
| 2028FYestimate | - | 2.360 | - | - | 1,400 | 30.93 |
| 2027FYestimate | - | 2.053 | - | - | 1,272 | 35.56 |
| 2026FY | 1.930 | 1.923 | 1.160 | 1,215 | 1,207 | 36.61 |
| 2025FY | 1.920 | 1.899 | 0.459 | 1,220 | 1,216 | 26.80 |
| 2024FY | 1.770 | 1.781 | 1.045 | 1,159 | 1,159 | 40.48 |
| 2023FY | 1.990 | 2.001 | 1.762 | 1,137 | 1,143 | 41.02 |
| 2022FY | 1.973 | 1.980 | 1.657 | 1,106 | 1,105 | 43.93 |
| 2021FY | 1.688 | 1.640 | 0.867 | 931.03 | 924.08 | 66.71 |
| 2020FY | 1.138 | 1.075 | 1.454 | 738.69 | 726.77 | 58.04 |
| 2019FY | 1.128 | 1.147 | 0.617 | 714.01 | 720.12 | 46.23 |
| 2018FY | 1.135 | 1.110 | 0.828 | 642.99 | 636.45 | 32.59 |
| 2017FY | 0.930 | 0.904 | 0.507 | 563 | 556.6 | 31.59 |
| 2016FY | 0.900 | 0.904 | 0.700 | 499.02 | 493.13 | 81.11 |
| 2015FY | 0.850 | 0.848 | 0.723 | 452.25 | 451.56 | 85.88 |
| 2014FY | 0.848 | 0.842 | 0.750 | 357.76 | 357.09 | 86.14 |
| 2013FY | 0.800 | 0.798 | 0.763 | 310.58 | 310.82 | 91.25 |
| 2012FY | 0.815 | 0.828 | 0.760 | 314.56 | 316.01 | 89.57 |
| 2011FY | 0.783 | 0.762 | 0.755 | 289.96 | 286.74 | 93.29 |
| 2010FY | 0.765 | 0.710 | 0.735 | 269.05 | 269.76 | 95.43 |
Quarterly results
2027Q1 revenue 299.71, from 286.56 a year earlier. Operating margin 13.4%, from 17.7% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2027FY E 2.05 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2027FY | E | per share | 2026-11-10 | 2.05 | +0.4% |
| 2027Q2 | E | per share | 2026-11-10 | 0.47 | -0.7% |
| 2027FY | R | per share | 2026-11-10 | 1.31 | -1.5% |
| 2027Q2 | R | per share | 2026-11-10 | 0.31 | -1.6% |
| 2027FY | S | USD millions | 2026-11-10 | 1,272 | +0.1% |
| 2027Q2 | S | - | 2026-11-10 | 308.75 | +0.0% |
| 2027Q1 | E | per share | 2026-10-22 | 0.44 | -0.7% |
| 2027Q1 | S | - | 2026-10-22 | 292.6 | 0.0% |
| 2027Q1 | R | per share | 2026-10-02 | 0.26 | -25.9% |
| 2026FY | E | per share | 2026-08-11 | 1.92 | 0.0% |
| 2026Q4 | E | per share | 2026-08-11 | 0.52 | 0.0% |
| 2026FY | S | USD millions | 2026-08-11 | 1,207 | +0.0% |
| 2026Q4 | S | - | 2026-08-11 | 314.68 | +0.0% |
| 2026FY | R | per share | 2026-07-21 | 1.17 | 0.0% |
| 2026Q4 | R | per share | 2026-07-21 | 0.40 | 0.0% |
| 2026Q3 | E | per share | 2026-05-05 | 0.53 | 0.0% |
| 2026Q3 | S | - | 2026-05-05 | 316.11 | 0.0% |
| 2026Q3 | R | per share | 2026-05-04 | 0.39 | +0.1% |
| 2026Q2 | E | per share | 2026-01-21 | 0.43 | 0.0% |
| 2026Q2 | R | per share | 2026-01-21 | 0.31 | 0.0% |
| 2026Q2 | S | - | 2026-01-21 | 290.47 | 0.0% |
| 2026Q1 | S | - | 2025-10-29 | 291.32 | -0.1% |
| 2026Q1 | E | per share | 2025-10-21 | 0.42 | 0.0% |
| 2026Q1 | R | per share | 2025-10-21 | 0.30 | 0.0% |
| 2025FY | E | per share | 2025-08-04 | 1.90 | +0.0% |
| 2025Q4 | E | per share | 2025-08-04 | 0.50 | 0.0% |
| 2025FY | S | USD millions | 2025-08-04 | 1,216 | +0.0% |
| 2025Q4 | S | - | 2025-08-04 | 314.61 | 0.0% |
| 2025FY | R | per share | 2025-07-21 | 0.88 | 0.0% |
| 2025Q4 | R | per share | 2025-07-21 | 0.32 | 0.0% |
| 2025Q3 | E | per share | 2025-04-21 | 0.51 | 0.0% |
| 2025Q3 | R | per share | 2025-04-21 | 0.33 | 0.0% |
| 2025Q3 | S | - | 2025-04-21 | 317.19 | 0.0% |
| 2025Q2 | E | per share | 2025-02-03 | 0.39 | -0.2% |
| 2025Q2 | S | - | 2025-02-03 | 285.78 | -0.1% |
| 2025Q2 | R | per share | 2025-01-13 | 0.22 | 0.0% |
| 2025Q1 | E | per share | 2024-10-28 | 0.38 | 0.0% |
| 2025Q1 | S | - | 2024-10-28 | 280.22 | 0.0% |
| 2025Q1 | R | per share | 2024-10-21 | 0.21 | 0.0% |
| 2024Q4 | S | - | 2024-08-02 | 306.49 | +0.0% |
| 2024FY | R | per share | 2024-07-27 | 1.11 | 0.0% |
| 2024FY | E | per share | 2024-07-18 | 1.78 | +0.0% |
| 2024Q4 | E | per share | 2024-07-18 | 0.49 | 0.0% |
| 2024FY | S | USD millions | 2024-07-18 | 1,159 | 0.0% |
| 2024Q4 | R | per share | 2024-07-15 | 0.33 | 0.0% |
| 2024Q3 | E | per share | 2024-04-30 | 0.45 | +0.4% |
| 2024Q3 | R | per share | 2024-04-30 | 0.29 | +2.9% |
| 2024Q3 | S | - | 2024-04-30 | 292.15 | -0.1% |
| 2023FY | E | per share | 2023-08-04 | 2.00 | +0.5% |
| 2023FY | S | USD millions | 2023-08-04 | 1,143 | +0.0% |
| 2023FY | R | per share | 2023-07-26 | 1.75 | 0.0% |
Estimate history
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | 0.828 | 0.617 | 1.454 | 0.867 | 1.657 | 1.762 | 1.045 | 0.459 | 1.158 | 1.0934 | - |
| Sales USD millions | 643 | 714 | 739 | 931 | 1,106 | 1,137 | 1,159 | 1,220 | 1,215 | 1,228 | - |
| Shares million shares | 150 | 152 | 154 | 156 | 157 | 158 | 158 | 155 | 156 | - | 157 |
| Metric | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | 0.209 | 0.217 | 0.142 | -0.114 | 0.244 | 0.242 | 0.324 | 0.348 | 0.179 |
| Sales USD millions | 289 | 297 | 316 | 317 | 287 | 296 | 311 | 321 | 300 |
| Shares million shares | 159 | 158 | 157 | 155 | 156 | 156 | 157 | 156 | 157 |
Income statement, annual
| Metric | TTM | 2026FY6/30/2026 | 2025FY6/30/2025 | 2024FY6/30/2024 | 2023FY6/30/2023 | 2022FY6/30/2022 | 2021FY6/30/2021 | 2020FY6/30/2020 | 2019FY6/30/2019 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,228.19 | 1,215.04-0.4% | 1,219.63+5.2% | 1,159.06+2.0% | 1,136.70+2.8% | 1,105.60+18.8% | 931.03+26.0% | 738.69+3.5% | 714.01 |
| Cost of Goods Sold Incl. D&A | 418.05 | 436.11-1.0% | 440.59+14.1% | 385.99+5.2% | 366.89-4.1% | 382.60+17.2% | 326.58+15.8% | 282.10-1.1% | 285.37 |
| Gross Profit | 810.15 | 778.930.0% | 779.04+0.8% | 773.07+0.4% | 769.82+6.5% | 723.00+19.6% | 604.45+32.4% | 456.59+6.5% | 428.63 |
| Selling, General and Administrative Excl. Other | 548.24 | 503.47-4.3% | 526.10+5.6% | 498.06+1.8% | 489.11+9.8% | 445.53+25.6% | 354.62+18.4% | 299.58+0.2% | 299.09 |
| Research and Development | 96.87 | 94.77-4.8% | 99.50+2.9% | 96.66+4.5% | 92.49+6.1% | 87.14+23.4% | 70.60+8.3% | 65.19+4.5% | 62.41 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.90 | 0.00 | 0.00 | 0.00 |
| Operating Income | 261.91 | 275.45+8.9% | 252.94-8.0% | 275.01-2.0% | 280.71+1.5% | 276.56+10.7% | 249.84+59.1% | 157.02+21.2% | 129.54 |
| Interest Expense | 12.49 | 15.06-23.6% | 19.72-32.6% | 29.26+99.5% | 14.67-16.9% | 17.66-21.7% | 22.55+53.5% | 14.69-32.3% | 21.70 |
| Unusual Expense | 26.94 | 29.43-80.5% | 150.68+121.5% | 68.04 | -67.56 | -35.21-143.7% | 80.59 | -0.40-102.2% | 18.35 |
| Net Income Before Taxes | 227.38 | 240.68+144.4% | 98.46-47.0% | 185.69-45.2% | 338.66+12.4% | 301.39+103.4% | 148.18-46.4% | 276.48+146.8% | 112.02 |
| Income Taxes | 55.41 | 58.82+134.7% | 25.06+42.5% | 17.58-67.0% | 53.22+39.0% | 38.29+345.8% | 8.59-81.8% | 47.18+196.0% | 15.94 |
| Consolidated Net Income | 171.97 | 181.84+147.9% | 73.36-56.4% | 168.07-41.1% | 285.37+8.5% | 262.98+88.5% | 139.50-39.1% | 229.07+138.7% | 95.97 |
| Net Income From Continuing Operations | 171.97 | 181.84+147.9% | 73.36-56.4% | 168.07-41.1% | 285.19+4.9% | 271.93+93.8% | 140.32-38.7% | 229.07+138.7% | 95.97 |
| Net Income | 171.97 | 181.84+147.9% | 73.36-56.4% | 168.07-41.1% | 285.19+4.9% | 271.93+93.8% | 140.32-38.7% | 229.07+138.7% | 95.97 |
| EPS (Recurring) per share | 1.21 | 1.29+15.2% | 1.12-16.4% | 1.34-8.8% | 1.47-2.6% | 1.51+24.8% | 1.21-16.6% | 1.45+107.1% | 0.70 |
| EPS (Basic, Before Extraordinaries) per share | 1.10 | 1.17+148.9% | 0.47-56.1% | 1.07-40.9% | 1.81+4.6% | 1.73+90.1% | 0.91-39.3% | 1.50+134.4% | 0.64 |
| EPS (Diluted) per share | 1.09 | 1.16+152.2% | 0.46-56.2% | 1.05-40.3% | 1.76+6.0% | 1.66+90.8% | 0.87-40.0% | 1.45+133.9% | 0.62 |
| EBITDA | 358.68 | 372.81+2.7% | 362.84-6.2% | 386.72-0.3% | 387.95+2.7% | 377.63+11.9% | 337.58+40.8% | 239.75+15.4% | 207.72 |
| Non-Operating Income (Expense) | 4.90 | 9.71-39.0% | 15.93+99.6% | 7.98+58.0% | 5.05-30.5% | 7.27+391.2% | 1.48-98.9% | 133.75+493.7% | 22.53 |
| Other After Tax Adjustments | 0.00 | -0.02 | -0.04 | -0.03 | -0.07 | -0.12 | -0.09 | -0.22 | -0.10 |
| Stock Option Compensation Expense | 35.14 | 33.02+1.2% | 32.63+4.8% | 31.13-2.2% | 31.84-11.2% | 35.87+2.2% | 35.09+41.5% | 24.80+2.8% | 24.13 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | 66.62 | 66.62 | 62.71 | 56.95 | 46.34 | 52.30 | 129.67 | 45.61 | 66.94 |
| Price To Sales Ratio ratio | 9.32 | 9.13 | 6.74 | 9.94 | 11.62 | 12.86 | 19.58 | 14.09 | 11.36 |
| Gross Margin % | 65.96 | 64.11 | 63.88 | 66.70 | 67.72 | 65.39 | 64.92 | 61.81 | 60.03 |
| Operating Margin % | 21.32 | 22.67 | 20.74 | 23.73 | 24.69 | 25.01 | 26.83 | 21.26 | 18.14 |
| Net Margin % | 14.00 | 14.97 | 6.02 | 14.50 | 25.09 | 24.60 | 15.07 | 31.01 | 13.44 |
| Shares Outstanding million shares | 157.05 | 156.10+0.7% | 154.97-2.1% | 158.22+0.4% | 157.64+0.6% | 156.64+0.5% | 155.82+1.3% | 153.81+1.4% | 151.74 |
| Market Capitalization | 11,442.51 | 11,442.51+41.9% | 8,065.66-28.6% | 11,290.97-12.1% | 12,851.58-5.3% | 13,574.42-22.6% | 17,540.10+72.7% | 10,154.30+28.8% | 7,883.71 |
Income statement, quarterly
| Metric | 2027Q19/30/2026 | 2026Q46/30/2026 | 2026Q33/31/2026 | 2026Q212/31/2025 | 2026Q19/30/2025 | 2025Q46/30/2025 | 2025Q33/31/2025 | 2025Q212/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 299.71+4.6% | 321.19+1.3% | 311.42-1.5% | 295.88-0.4% | 286.56-1.0% | 316.96+3.5% | 316.18+4.2% | 297.03+9.0% |
| Cost of Goods Sold Incl. D&A | 101.68+5.5% | 111.70+5.6% | 101.97+0.5% | 102.69+2.2% | 96.36-5.1% | 105.82+4.5% | 101.49+3.4% | 100.45+5.9% |
| Gross Profit | 198.03+4.1% | 209.49-0.8% | 209.44-2.4% | 193.19-1.7% | 190.19+1.2% | 211.14+3.1% | 214.69+4.6% | 196.58+10.6% |
| Selling, General and Administrative Excl. Other | 157.72+13.1% | 130.78-4.0% | 129.13+0.7% | 130.61-8.2% | 139.40+3.3% | 136.30+31.2% | 128.17-3.8% | 142.35+5.4% |
| Research and Development | 26.34+8.7% | 23.95-8.0% | 23.45-4.6% | 23.12-7.6% | 24.24+1.6% | 26.03+8.5% | 24.58-4.6% | 25.02+9.2% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 40.31-20.6% | 78.71+5.2% | 80.31-7.2% | 62.58+15.4% | 50.79-4.1% | 74.85-25.9% | 86.52+20.2% | 54.23+27.0% |
| Interest Expense | 2.90-47.0% | 2.78-41.4% | 3.22-27.8% | 3.59-27.6% | 5.47-1.6% | 4.74-20.1% | 4.46-39.8% | 4.96-36.3% |
| Unusual Expense | 3.71+18.5% | 10.29-89.6% | 4.82-89.9% | 8.12+19.2% | 3.13-75.9% | 98.71+79.0% | 47.81+860.0% | 6.81+45.5% |
| Net Income Before Taxes | 34.69-27.7% | 70.68 | 71.22+86.1% | 50.78+18.4% | 47.99+19.5% | -22.86-154.9% | 38.27-37.3% | 42.88+28.4% |
| Income Taxes | 6.40-34.8% | 16.06 | 20.18+28.6% | 12.78+59.9% | 9.81+49.3% | -5.18-584.1% | 15.69+30.4% | 7.99+35.0% |
| Consolidated Net Income | 28.29-25.9% | 54.64 | 51.04+125.9% | 38.00+8.9% | 38.18+13.7% | -17.70-143.6% | 22.59-53.9% | 34.89+27.1% |
| Net Income From Continuing Operations | 28.29-25.9% | 54.64 | 51.04+125.9% | 38.00+8.9% | 38.18+13.7% | -17.70-143.6% | 22.59-53.9% | 34.89+27.1% |
| Net Income | 28.29-25.9% | 54.64 | 51.04+125.9% | 38.00+8.9% | 38.18+13.7% | -17.70-143.6% | 22.59-53.9% | 34.89+27.1% |
| EPS (Recurring) per share | 0.20-23.1% | 0.39+18.2% | 0.350.0% | 0.28+12.0% | 0.260.0% | 0.33-32.7% | 0.35+6.1% | 0.25+31.6% |
| EPS (Basic, Before Extraordinaries) per share | 0.18-28.0% | 0.35 | 0.33+135.7% | 0.24+9.1% | 0.25+19.0% | -0.11-142.3% | 0.14-54.8% | 0.22+29.4% |
| EPS (Diluted) per share | 0.18-25.0% | 0.35 | 0.32+128.6% | 0.24+9.1% | 0.24+14.3% | -0.11-144.0% | 0.14-54.8% | 0.22+29.4% |
| EBITDA | 64.04-14.8% | 102.88+0.9% | 104.48-8.4% | 87.29+7.4% | 75.13-7.4% | 101.96-21.0% | 114.09+14.9% | 81.31+15.3% |
| Non-Operating Income (Expense) | 0.99-82.9% | 5.05-12.0% | -1.05-126.1% | -0.09-121.4% | 5.80+1.0% | 5.74+224.3% | 4.02+168.0% | 0.42-86.8% |
| Other After Tax Adjustments | -0.00 | 0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.00 | -0.00 |
| Stock Option Compensation Expense | 11.38+23.2% | 4.25+25.0% | 8.53-6.9% | 10.98-6.7% | 9.24+10.4% | 3.40-42.4% | 9.16+41.4% | 11.77+17.3% |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | 66.62 | 101.48 | 101.65 | 120.22 | 122.67 | 62.71 | 59.59 | 76.77 |
| Price To Sales Ratio ratio | 9.32 | 9.13 | 6.79 | 7.60 | 7.15 | 6.53 | 7.71 | 9.67 |
| Gross Margin % | 66.07 | 65.22 | 67.25 | 65.29 | 66.37 | 66.61 | 67.90 | 66.18 |
| Operating Margin % | 13.45 | 24.51 | 25.79 | 21.15 | 17.72 | 23.61 | 27.36 | 18.26 |
| Net Margin % | 9.44 | 17.01 | 16.39 | 12.84 | 13.32 | -5.58 | 7.14 | 11.75 |
| Shares Outstanding million shares | 157.05+0.8% | 156.10+0.7% | 156.52-0.2% | 155.88-1.3% | 155.75-2.0% | 154.97-2.1% | 156.76-0.5% | 157.92+0.5% |
| Market Capitalization | 11,442.51+32.2% | 11,061.60+37.1% | 8,176.23-11.8% | 9,163.36-19.9% | 8,653.25-31.8% | 8,065.66-28.6% | 9,268.70-16.2% | 11,444.99-6.2% |
Balance sheet, annual
| Metric | 2026FY6/30/2026 | 2025FY6/30/2025 | 2024FY6/30/2024 | 2023FY6/30/2023 | 2022FY6/30/2022 | 2021FY6/30/2021 | 2020FY6/30/2020 | 2019FY6/30/2019 | 2018FY6/30/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 264.71+63.2% | 162.19+6.1% | 152.86-25.2% | 204.31-17.3% | 247.03+6.7% | 231.55-14.5% | 270.89+63.2% | 166.03-8.6% | 181.75 |
| Short Term Receivables | 220.50+6.6% | 206.88-14.3% | 241.39+10.5% | 218.47+12.3% | 194.55+33.8% | 145.38+18.6% | 122.53-10.9% | 137.47+14.3% | 120.30 |
| Inventories | 195.74+3.3% | 189.45+5.4% | 179.73+4.7% | 171.64+21.6% | 141.12+20.9% | 116.75+13.2% | 103.15+13.3% | 91.05+6.3% | 85.65 |
| Other Current Assets | 63.45+27.4% | 49.79+14.6% | 43.43+60.4% | 27.07+18.4% | 22.86+35.1% | 16.92-30.5% | 24.34+34.8% | 18.06+69.3% | 10.67 |
| Total Current Assets | 744.40+22.4% | 608.30-1.5% | 617.42-0.7% | 621.48+2.6% | 605.56+18.6% | 510.61-2.0% | 520.92+26.2% | 412.61+3.6% | 398.37 |
| Net Property, Plant & Equipment | 299.17-6.3% | 319.12-6.8% | 342.44+5.5% | 324.53+12.4% | 288.80+2.5% | 281.74+13.5% | 248.29+61.2% | 154.04+6.0% | 145.35 |
| Total Investments and Advances | 245.83-3.2% | 253.83+0.7% | 252.15 | 0.00 | 0.00-100.0% | 0.28 | 0.00 | 0.00-100.0% | 2.61 |
| Long-Term Note Receivable | 7.56 | - | - | - | - | - | - | - | - |
| Intangible Assets | 1,278.82-5.0% | 1,346.53-9.0% | 1,479.74+5.1% | 1,407.38+4.0% | 1,353.62-7.2% | 1,459.04+17.2% | 1,244.85-5.1% | 1,312.10+25.7% | 1,044.22 |
| Deferred Tax Assets | 92.27+795.0% | 10.31-90.6% | 109.32+15.0% | 95.02+24.7% | 76.22-12.3% | 86.88+18.4% | 73.35+11.8% | 65.60 | - |
| Other Assets | 10.95-44.6% | 19.78+63.2% | 12.12-95.8% | 285.30+509.2% | 46.83+314.4% | 11.30-16.4% | 13.52+138.4% | 5.67+113.2% | 2.66 |
| Total Assets | 2,678.99+4.7% | 2,557.87-9.1% | 2,813.19+2.9% | 2,733.72+15.3% | 2,371.03+0.9% | 2,349.84+11.8% | 2,100.94+7.7% | 1,950.01+22.4% | 1,593.20 |
| Short Term Debt Incl. Current Port. of LT Debt | 14.94+6.0% | 14.10+9.1% | 12.92+15.4% | 11.20-54.2% | 24.43+1.4% | 24.10+9.3% | 22.04+76.3% | 12.50 | 0.00 |
| Accounts Payable | 26.70+5.5% | 25.31-33.3% | 37.97+47.9% | 25.68-24.2% | 33.87+15.3% | 29.38+27.2% | 23.09+42.4% | 16.21-12.1% | 18.45 |
| Income Tax Payable | 3.59-66.7% | 10.77+190.3% | 3.71-69.1% | 12.02-9.2% | 13.24+147.9% | 5.34+124.4% | 2.38-58.7% | 5.76-35.1% | 8.88 |
| Other Current Liabilities | 118.47-5.7% | 125.67+19.9% | 104.78+31.6% | 79.61-23.8% | 104.49+11.8% | 93.46+58.0% | 59.17-12.4% | 67.51+29.4% | 52.18 |
| Total Current Liabilities | 163.70-6.9% | 175.85+10.3% | 159.38+24.0% | 128.51-27.0% | 176.02+15.6% | 152.28+42.8% | 106.67+4.6% | 101.98+28.3% | 79.51 |
| Long Term Debt | 274.15-36.2% | 429.96+5.7% | 406.62-8.4% | 443.77+47.2% | 301.54-23.9% | 396.45-3.7% | 411.49-16.5% | 492.66+45.3% | 339.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 111.57+1708.3% | 6.17-96.3% | 165.19-10.2% | 184.00+5.0% | 175.22-2.7% | 180.01+3.2% | 174.44+12.3% | 155.35+80.0% | 86.29 |
| Other Liabilities | 21.34-21.2% | 27.08+105.8% | 13.16+20.5% | 10.92-36.7% | 17.24-65.4% | 49.86+83.6% | 27.15-21.1% | 34.42+268.5% | 9.34 |
| Total Liabilities | 570.77-10.7% | 639.06-14.1% | 744.34-3.0% | 767.20+14.5% | 670.02-13.9% | 778.61+8.2% | 719.75-8.2% | 784.42+52.6% | 514.14 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 2,108.22+9.9% | 1,918.81-7.3% | 2,068.85+5.2% | 1,966.52+15.6% | 1,701.77+8.9% | 1,562.97+13.2% | 1,381.19+18.5% | 1,165.59+8.0% | 1,079.06 |
| Total Shareholders Equity | 2,108.22+9.9% | 1,918.81-7.3% | 2,068.85+5.2% | 1,966.52+15.6% | 1,701.77+8.9% | 1,562.97+13.2% | 1,381.19+18.5% | 1,165.59+8.0% | 1,079.06 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -0.76-109.2% | 8.26 | 0.00 | 0.00 | 0.00 |
| Total Equity | 2,108.22+9.9% | 1,918.81-7.3% | 2,068.85+5.2% | 1,966.52+15.6% | 1,701.01+8.3% | 1,571.23+13.8% | 1,381.19+18.5% | 1,165.59+8.0% | 1,079.06 |
| Total Liabilities & Stockholders Equity | 2,678.99+4.7% | 2,557.87-9.1% | 2,813.19+2.9% | 2,733.72+15.3% | 2,371.03+0.9% | 2,349.84+11.8% | 2,100.94+7.7% | 1,950.01+22.4% | 1,593.20 |
| Book Value Per Share per share | 13.51+9.1% | 12.38-5.4% | 13.08+4.9% | 12.47+14.8% | 10.86+8.3% | 10.03+11.7% | 8.98+16.9% | 7.68+7.1% | 7.17 |
| Tangible Book Value Per Share per share | 5.31+43.9% | 3.69-0.8% | 3.72+4.8% | 3.55+59.9% | 2.22+231.3% | 0.67-24.7% | 0.89 | -0.97-521.7% | 0.23 |
| Full-Time Employees people | 3,000-3.2% | 3,1000.0% | 3,100+1.6% | 3,050+1.7% | 3,000+15.4% | 2,600+13.0% | 2,300+2.0% | 2,255+16.1% | 1,943 |
| Price to Book Ratio ratio | 5.28 | 4.00 | 5.60 | 6.54 | 7.98 | 11.22 | 7.35 | 6.88 | 5.25 |
| Return on Assets % | 6.94 | 2.73 | 6.06 | 11.17 | 11.52 | 6.31 | 11.31 | 5.42 | 8.00 |
| Return on Equity % | 9.03 | 3.68 | 8.33 | 15.55 | 16.66 | 9.53 | 17.99 | 8.55 | 12.43 |
| Return on Invested Capital % | 7.63 | 3.12 | 6.79 | 11.83 | 13.57 | 7.16 | 12.78 | 5.79 | 8.89 |
| Quick Ratio ratio | 3.35 | 2.38 | 2.75 | 3.50 | 2.64 | 2.59 | 3.92 | 3.15 | 3.93 |
| Current Ratio ratio | 4.55 | 3.46 | 3.87 | 4.84 | 3.44 | 3.35 | 4.88 | 4.05 | 5.01 |
Cash flow, annual
| Metric | TTM | 2026FY6/30/2026 | 2025FY6/30/2025 | 2024FY6/30/2024 | 2023FY6/30/2023 | 2022FY6/30/2022 | 2021FY6/30/2021 | 2020FY6/30/2020 | 2019FY6/30/2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 171.97 | 181.86+147.8% | 73.40-56.3% | 168.10-41.1% | 285.44+8.5% | 263.10+88.5% | 139.59-39.1% | 229.30+138.7% | 96.07 |
| Depreciation | 96.75 | 97.36-11.4% | 109.90-1.6% | 111.71+4.2% | 107.24+6.1% | 101.07+15.2% | 87.75+6.1% | 82.74+5.8% | 78.17 |
| Other Funds (Non Cash) | 50.07 | 40.96-71.5% | 143.82+109.3% | 68.72 | -18.14-176.2% | 23.80-80.7% | 123.00 | -114.70-335.5% | 48.71 |
| Funds from Operations | 329.15 | 333.38+20.8% | 276.02-10.7% | 309.09-10.4% | 344.97-12.6% | 394.79+22.3% | 322.90+53.4% | 210.46+0.5% | 209.37 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 8.45 | -41.30-457.9% | 11.54 | -10.11 | -90.58 | -69.52-337.6% | 29.26 | -5.25 | -27.75 |
| Income Taxes Payable | 1.15 | -23.05-372.1% | 8.47 | -10.60 | -2.49-193.3% | 2.67-80.1% | 13.43 | -7.23 | -9.52 |
| Cash from Operating Activities | 337.60 | 292.07+1.6% | 287.56-3.8% | 298.98+17.5% | 254.39-21.8% | 325.27-7.6% | 352.16+71.6% | 205.22+13.0% | 181.62 |
| Capital Expenditures | -29.40 | -28.85 | -31.01 | -62.88 | -38.24 | -44.91 | -44.30 | -51.74 | -25.41 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | -169.71 | -101.18 | 0.00 | -225.35 | 0.00 | -289.49 |
| Sale of Fixed Assets and Businesses | 0.00 | 4.62+88.6% | 2.45 | 0.00-100.0% | 17.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 6.68 | 6.04 | -6.62-122.4% | 29.55 | -144.04 | -51.94-298.7% | 26.14-66.8% | 78.84 | -21.90 |
| Purchase of Investments | 0.00 | 0.00 | -15.00 | -5.53 | -252.50 | -78.00 | -40.24 | -70.19 | -43.48 |
| Sale Or Maturity of Investments | 6.68 | 6.04-27.9% | 8.38-76.1% | 35.08-67.7% | 108.45+316.3% | 26.05-60.8% | 66.38-55.5% | 149.03+590.6% | 21.58 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -22.72 | -18.19 | -35.18 | -203.03 | -265.65 | -96.85 | -243.52-998.9% | 27.09 | -336.80 |
| Cash Dividends Paid | -50.03 | -49.92 | -50.39 | -50.42 | -50.28 | -50.19 | -49.62 | -48.90 | -48.36 |
| Change in Capital Stock | 51.65 | 38.94 | -223.99 | -19.11-286.4% | 10.25 | -83.80-482.5% | 21.91+5.0% | 20.87-7.5% | 22.55 |
| Repurchase of Common Pref Stock | -41.65 | -41.67 | -275.73 | -80.04 | -19.56 | -160.95 | -43.18 | -50.11 | -15.40 |
| Sale of Common Pref Stock | 93.30 | 80.62+55.8% | 51.74-15.1% | 60.94+104.4% | 29.81-61.4% | 77.16+18.5% | 65.09-8.3% | 70.98+87.0% | 37.95 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -100.00 | -146.00-640.7% | 27.00 | -31.00-133.0% | 94.00 | -85.50 | -15.50 | -148.50-189.2% | 166.50 |
| Change in Long Term Debt | -100.00 | -146.00-640.7% | 27.00 | -31.00-133.0% | 94.00 | -85.50 | -15.50 | -148.50-189.2% | 166.50 |
| Issuance of Long Term Debt | 0.00 | 0.00-100.0% | 104.00-53.8% | 225.00-63.7% | 619.66+588.5% | 90.00-64.8% | 256.00+540.0% | 40.00-93.1% | 580.00 |
| Reduction of Long Term Debt | -100.00 | -146.00 | -77.00 | -256.00 | -525.66 | -175.50 | -271.50 | -188.50 | -413.50 |
| Net Financing Active Other Cash Flow | -10.15 | -12.14 | -6.52 | -21.87 | -31.35 | -23.37 | -19.34 | -7.27 | -6.30 |
| Other Financing Activities Uses | -10.15 | -12.14 | -6.52 | -21.87 | -31.35 | -24.16 | -19.34 | -7.27 | -6.30 |
| Cash from Financing Activities | -108.53 | -169.11 | -253.91 | -122.40-641.1% | 22.62 | -242.85 | -62.55 | -183.80-236.8% | 134.38 |
| Exchange Rate Effect | -1.28 | -2.24-118.8% | 11.93 | -2.33 | -3.36 | -12.09-289.8% | 6.37 | -2.77 | -0.31 |
| Net Change in Cash | 205.07 | 102.53+886.8% | 10.39 | -28.78-459.8% | 8.00 | -26.52-150.5% | 52.47+14.7% | 45.74 | -21.10 |
| Free Cash Flow | 308.20 | 263.22+2.6% | 256.55+8.7% | 236.10+9.2% | 216.15-22.9% | 280.36-8.9% | 307.86+100.6% | 153.47-1.8% | 156.21 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow ratio | 44.33 | 52.00 | 39.86 | 62.04 | 79.66 | 61.79 | 70.58 | 99.50 | 75.19 |
| Deferred Taxes & Investment Tax Credit | - | 13.20 | -51.11 | -39.45 | -29.57-533.6% | 6.82 | -27.43-308.9% | 13.13 | -13.58 |
Balance sheet, quarterly
| Metric | 2027Q19/30/2026 | 2026Q46/30/2026 | 2026Q33/31/2026 | 2026Q212/31/2025 | 2026Q19/30/2025 | 2025Q46/30/2025 | 2025Q33/31/2025 | 2025Q212/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 350.04+141.5% | 264.71+63.2% | 209.82+49.2% | 172.88-2.6% | 144.96-22.7% | 162.19+6.1% | 140.67-3.2% | 177.55+30.9% |
| Short Term Receivables | 209.80+14.1% | 220.50+6.6% | 217.92-10.4% | 189.49-13.1% | 183.90-17.8% | 206.88-14.3% | 243.14+6.7% | 217.94+5.1% |
| Inventories | 197.67-2.7% | 195.74+3.3% | 201.18+5.3% | 205.45+9.1% | 203.19+9.8% | 189.45+5.4% | 191.08+6.5% | 188.37+4.2% |
| Other Current Assets | 67.33-13.1% | 63.45+27.4% | 59.14+13.0% | 69.62+37.1% | 77.46+48.1% | 49.79+14.6% | 52.35-9.7% | 50.78-23.9% |
| Total Current Assets | 824.83+35.3% | 744.40+22.4% | 688.05+9.7% | 637.43+0.4% | 609.51-6.0% | 608.30-1.5% | 627.24+2.7% | 634.64+7.4% |
| Net Property, Plant & Equipment | 292.17-6.1% | 299.17-6.3% | 301.31-10.2% | 302.63-9.7% | 311.06-9.4% | 319.12-6.8% | 335.72-1.5% | 335.14+0.0% |
| Total Investments and Advances | 245.61-5.0% | 245.83-3.2% | 246.03-3.3% | 250.04-3.7% | 258.61-1.7% | 253.83+0.7% | 254.51-2.1% | 259.58-0.7% |
| Intangible Assets | 1,259.11-5.3% | 1,278.82-5.0% | 1,296.87-8.2% | 1,315.55-7.7% | 1,329.02-9.5% | 1,346.53-9.0% | 1,412.31-5.7% | 1,425.66-6.9% |
| Deferred Tax Assets | - | 92.27+795.0% | - | - | - | 10.31-90.6% | - | - |
| Other Assets | 11.50+12.6% | 10.95-44.6% | 10.22-29.4% | 9.87-36.0% | 10.21-19.7% | 19.78+63.2% | 14.47+19.3% | 15.41+18.2% |
| Total Assets | 2,636.82+4.4% | 2,678.99+4.7% | 2,550.60-3.5% | 2,522.70-5.5% | 2,526.15-7.7% | 2,557.87-9.1% | 2,644.26-2.8% | 2,670.42-2.2% |
| Short Term Debt Incl. Current Port. of LT Debt | 214.99+1461.3% | 14.94+6.0% | 14.18+0.9% | 13.71+1.5% | 13.77+2.2% | 14.10+9.1% | 14.05+8.2% | 13.51+6.6% |
| Accounts Payable | 31.00+2.8% | 26.70+5.5% | 23.49-25.8% | 26.27-20.7% | 30.16-4.4% | 25.31-33.3% | 31.64+9.5% | 33.12+5.1% |
| Income Tax Payable | 2.71-4.9% | 3.59-66.7% | 2.97-18.2% | 2.48-21.0% | 2.85-9.2% | 10.77+190.3% | 3.63-70.0% | 3.14-52.8% |
| Other Current Liabilities | 112.57+15.1% | 118.47-5.7% | 112.64-6.0% | 97.97-12.1% | 97.77+4.1% | 125.67+19.9% | 119.88+25.1% | 111.48+32.1% |
| Total Current Liabilities | 361.27+149.9% | 163.70-6.9% | 153.28-9.4% | 140.43-12.9% | 144.54+1.7% | 175.85+10.3% | 169.20+12.9% | 161.26+19.2% |
| Long Term Debt | 70.56-81.5% | 274.15-36.2% | 276.14-32.6% | 337.19-11.6% | 380.70-1.2% | 429.96+5.7% | 409.45-15.0% | 381.62-29.7% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 23.51+108.6% | 111.57+1708.3% | 14.21-55.5% | 11.02-70.8% | 11.27-77.5% | 6.17-96.3% | 31.92-49.9% | 37.72-47.3% |
| Other Liabilities | 15.79-33.7% | 21.34-21.2% | 21.67+38.4% | 23.08+103.5% | 23.81+20.3% | 27.08+105.8% | 15.66+35.5% | 11.34-34.7% |
| Total Liabilities | 471.13-15.9% | 570.77-10.7% | 465.30-25.7% | 511.71-13.6% | 560.33-6.2% | 639.06-14.1% | 626.23-11.4% | 591.93-22.8% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 2,165.69+10.2% | 2,108.22+9.9% | 2,085.30+3.3% | 2,010.99-3.2% | 1,965.81-8.1% | 1,918.81-7.3% | 2,018.03+0.2% | 2,078.49+5.9% |
| Total Shareholders Equity | 2,165.69+10.2% | 2,108.22+9.9% | 2,085.30+3.3% | 2,010.99-3.2% | 1,965.81-8.1% | 1,918.81-7.3% | 2,018.03+0.2% | 2,078.49+5.9% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 2,165.69+10.2% | 2,108.22+9.9% | 2,085.30+3.3% | 2,010.99-3.2% | 1,965.81-8.1% | 1,918.81-7.3% | 2,018.03+0.2% | 2,078.49+5.9% |
| Total Liabilities & Stockholders Equity | 2,636.82+4.4% | 2,678.99+4.7% | 2,550.60-3.5% | 2,522.70-5.5% | 2,526.15-7.7% | 2,557.87-9.1% | 2,644.26-2.8% | 2,670.42-2.2% |
| Book Value Per Share per share | 13.79+9.3% | 13.51+9.1% | 13.32+3.5% | 12.90-2.0% | 12.62-6.2% | 12.38-5.4% | 12.87+0.6% | 13.16+5.3% |
| Tangible Book Value Per Share per share | 5.77+41.1% | 5.31+43.9% | 5.04+30.6% | 4.46+8.0% | 4.09-3.1% | 3.69-0.8% | 3.86+17.7% | 4.13+50.2% |
| Full-Time Employees people | - | 3,000-3.2% | - | - | - | 3,1000.0% | - | - |
| Price to Book Ratio ratio | 5.28 | 5.30 | 4.05 | 4.66 | 4.49 | 4.00 | 4.45 | 5.35 |
| Return on Assets % | 6.66 | 6.95 | 4.22 | 3.12 | 2.96 | 2.73 | 4.91 | 5.85 |
| Return on Equity % | 8.32 | 9.03 | 5.34 | 3.96 | 3.80 | 3.68 | 6.53 | 7.82 |
| Return on Invested Capital % | 1.27 | 2.29 | 2.16 | 1.62 | 1.63 | -0.75 | 0.93 | 1.42 |
| Quick Ratio ratio | 1.74 | 3.35 | 3.18 | 3.08 | 2.81 | 2.38 | 2.58 | 2.77 |
| Current Ratio ratio | 2.28 | 4.55 | 4.49 | 4.54 | 4.22 | 3.46 | 3.71 | 3.94 |
Cash flow, quarterly
| Metric | 2027Q19/30/2026 | 2026Q46/30/2026 | 2026Q33/31/2026 | 2026Q212/31/2025 | 2026Q19/30/2025 | 2025Q46/30/2025 | 2025Q33/31/2025 | 2025Q212/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | 28.29-25.9% | 54.62 | 51.05+126.0% | 38.01+8.9% | 38.19+13.7% | -17.68-143.6% | 22.59-54.0% | 34.89+27.0% |
| Depreciation | 23.73-2.5% | 24.14-11.0% | 24.17-12.3% | 24.71-8.8% | 24.34-13.5% | 27.11-3.4% | 27.57+1.0% | 27.08-2.6% |
| Other Funds (Non Cash) | 11.75+346.8% | 7.69-92.3% | 12.72+43.6% | 17.91-1.9% | 2.63-84.7% | 99.48+273.4% | 8.86-18.5% | 18.25-7.8% |
| Funds from Operations | 66.21-6.0% | 91.60+19.5% | 90.78+69.3% | 80.56+11.7% | 70.43-4.3% | 76.63-10.6% | 53.61-32.7% | 72.15+12.1% |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 6.90 | 3.81-82.3% | -4.12 | 1.85-84.8% | -42.85 | 21.57 | -12.49-1039.1% | 12.20-35.0% |
| Income Taxes Payable | -3.20 | -10.01-161.1% | 9.79+323.8% | 4.58 | -27.40 | 16.38 | 2.31-76.6% | -4.04-131.0% |
| Cash from Operating Activities | 73.11+165.0% | 95.42-2.8% | 86.66+110.7% | 82.41-2.3% | 27.59-56.8% | 98.20+30.1% | 41.12-49.2% | 84.35+1.5% |
| Capital Expenditures | -5.92 | -8.48 | -9.09 | -5.92 | -5.36 | -4.89 | -10.12 | -6.82 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00-100.0% | 0.00-100.0% | 0.00 | 0.00-100.0% | 4.62 | 0.66 | 0.00 | 1.79 |
| Purchase or Sale of Investments | 1.99+47.4% | 1.42-69.4% | 3.27+161.6% | 0.00 | 1.35 | 4.64-49.4% | 1.25 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 1.99+47.4% | 1.42-69.4% | 3.27+161.6% | 0.00 | 1.35-45.8% | 4.64-49.4% | 1.25 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -3.93-755.0% | -7.06-1822.0% | -5.82 | -5.92 | 0.60 | 0.41 | -8.87 | -5.03 |
| Cash Dividends Paid | -12.56 | -12.48 | -12.52 | -12.47 | -12.44 | -12.39 | -12.58 | -12.74 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 36.18+54.2% | -19.23 | 29.96 | 4.74 | 23.47-6.5% | -93.83-509.2% | -85.17-564.6% | -70.09 |
| Repurchase of Common Pref Stock | 0.00 | -41.65 | 0.00 | 0.00 | -0.02 | -100.06 | -100.05 | -75.63 |
| Sale of Common Pref Stock | 36.18+54.0% | 22.43+260.0% | 29.96+101.5% | 4.74-14.4% | 23.50-6.4% | 6.23-72.8% | 14.87-18.9% | 5.54+4.9% |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00-100.0% | -60.00-300.0% | -40.00 | -46.00 | 16.00 | 30.00 | 0.00-100.0% |
| Change in Long Term Debt | 0.00 | 0.00-100.0% | -60.00-300.0% | -40.00 | -46.00 | 16.00 | 30.00 | 0.00-100.0% |
| Issuance of Long Term Debt | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00 | 0.00 | 66.00 | 38.00 | 0.00-100.0% |
| Reduction of Long Term Debt | 0.00 | 0.00 | -60.00 | -40.00 | -46.00 | -50.00 | -8.00 | 0.00 |
| Net Financing Active Other Cash Flow | -7.24 | -1.50 | -0.16 | -1.25 | -9.23 | -0.23 | -0.29 | -1.01 |
| Other Financing Activities Uses | -7.24 | -1.50 | -0.16 | -1.25 | -9.23 | -0.23 | -0.29 | -1.01 |
| Cash from Financing Activities | 16.39 | -33.21 | -42.72 | -48.99 | -44.20 | -90.45 | -68.05 | -83.84 |
| Exchange Rate Effect | -0.25 | -0.26-101.9% | -1.19 | 0.41 | -1.21-123.6% | 13.36+153.0% | -1.08 | -5.47-259.9% |
| Net Change in Cash | 85.32 | 54.89+155.1% | 36.94 | 27.92 | -17.22-148.2% | 21.52+81.1% | -36.88-477.1% | -9.99 |
| Free Cash Flow | 67.20+202.4% | 86.94-6.8% | 77.58+150.3% | 76.49-1.3% | 22.22-59.4% | 93.31+62.2% | 31.00-52.0% | 77.53+13.6% |
| Price to Free Cash Flow ratio | 44.33 | 52.01 | 37.43 | 53.33 | 50.02 | 38.66 | 54.78 | 56.81 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2025 | 2026 | vs 2025 | 2026 share |
|---|---|---|---|---|
| Consumables | 972.29 | - | - | - |
| Instruments | 112.09 | - | - | - |
| Royalty | 23.69 | - | - | - |
| Service | 111.57 | - | - | - |
| Total Biological Products, (No Diagnostic Substances) revenue | - | 1,215.04 | - | 100.0% |
| Total | 1,219.64 | 1,215.04 | -0.4% | 100.0% |
| Name | 2025 | 2026 | vs 2025 | 2026 share |
|---|---|---|---|---|
| APAC, excluding Greater China | 77.26 | - | - | - |
| China | 100.46 | - | - | - |
| EMEA, excluding UK | 266.31 | - | - | - |
| Rest of World | 37.55 | - | - | - |
| United Kingdom | 54.83 | - | - | - |
| United States | 683.23 | 1,215.04 | +77.8% | 100.0% |
| Total | 1,219.64 | 1,215.04 | -0.4% | 100.0% |
| Name | 2025 | 2026 | vs 2025 | 2026 share |
|---|---|---|---|---|
| Consolidation, Policy | 3.13 | - | - | - |
| Diagnostics and Spatial Biology | 346.26 | - | - | - |
| Protein Sciences | 870.25 | - | - | - |
| Total Biological Products, (No Diagnostic Substances) revenue | - | 1,215.04 | - | 100.0% |
| Total | 1,219.64 | 1,215.04 | -0.4% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 4.93% | 7.7M | 156.2M | 2.84M |
| 2026-10-15 | 4.84% | 7.6M | 156.0M | 3.04M |
| 2026-09-30 | 4.74% | 7.4M | 156.0M | 3.48M |
| 2026-09-15 | 4.25% | 6.6M | 156.0M | 4.67M |
| 2026-08-31 | 3.78% | 5.9M | 156.0M | 4.72M |
| 2026-08-14 | 4.15% | 6.5M | 155.7M | 4.87M |
| 2026-07-31 | 5.95% | 9.3M | 156.0M | 5.03M |
| 2026-07-15 | 7.77% | 12.1M | 155.9M | 4.69M |
| 2026-06-30 | 10.21% | 15.9M | 155.9M | 4.11M |
| 2026-06-15 | 11.68% | 18.2M | 155.9M | 2.68M |
| 2026-05-29 | 8.88% | 13.8M | 155.9M | 2.60M |
| 2026-05-15 | 9.33% | 14.6M | 156.0M | 2.53M |
| 2026-04-30 | 8.55% | 13.3M | 156.0M | 2.32M |
| 2026-04-15 | 8.98% | 14.0M | 155.9M | 2.39M |
| 2026-03-31 | 9.12% | 14.1M | 154.6M | 2.44M |
| 2026-03-13 | 7.99% | 12.4M | 154.6M | 2.30M |
| 2026-02-27 | 6.84% | 10.6M | 154.6M | 2.16M |
| 2026-02-13 | 7.32% | 11.3M | 154.6M | 2.08M |
| 2026-01-30 | 6.37% | 9.8M | 154.6M | 2.01M |
| 2026-01-15 | 6.73% | 10.4M | 153.9M | 1.90M |
Option chain
Expiry 2026-11-20 · underlying 73.00, quoted 13 Nov 08:01 ET · ATM 75.00
Option quotes 12 Nov 11:48 ET. A date on a row is older than the last session (12 Nov). 27 rows.
Implied move 3.18% into expiry (call 0.025 + put 2.300 = 2.325 on 73.00)
Put/call open interest 2.85 (342 puts / 120 calls) · Put/call volume — no calls
IV change is points against the prior close.
| Type | Strike | Money | Bid | Ask | Last | Chg | IV | Open int | Volume | Last size | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| call 1 Jan | 40.00 | ITM | 30.70 | 35.00 | 0.00 | 0.00 | 379.5% -2.2 | 0 | 0 | 0 | 0.911 | -0.418 | 0.017 |
| put 10 Nov | OTM | 0.00 | 2.15 | 0.36 | 0.00 | 361.2% 0.0 | 24 | 0 | 0 | -0.089 | -0.371 | 0.018 | |
| call 19 Oct | 45.00 | ITM | 25.70 | 30.00 | 27.53 | 0.00 | 322.5% -1.2 | 0 | 0 | 0 | 0.895 | -0.404 | 0.019 |
| put 1 Jan | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 305.3% 0.0 | 0 | 0 | 0 | -0.105 | -0.355 | 0.021 | |
| call 19 Oct | 50.00 | ITM | 20.80 | 25.00 | 22.55 | 0.00 | 268.9% -1.2 | 0 | 0 | 0 | 0.875 | -0.382 | 0.022 |
| put 19 Oct | OTM | 0.00 | 2.15 | 0.58 | 0.00 | 266.0% 0.0 | 6 | 0 | 0 | -0.125 | -0.366 | 0.022 | |
| call 19 Oct | 55.00 | ITM | 15.70 | 20.00 | 17.54 | 0.00 | 219.5% -1.2 | 0 | 0 | 0 | 0.849 | -0.356 | 0.025 |
| put 27 Oct | OTM | 0.00 | 2.15 | 0.71 | 0.00 | 217.4% 0.0 | 301 | 0 | 0 | -0.151 | -0.340 | 0.025 | |
| call 1 Jan | 60.00 | ITM | 10.70 | 15.00 | 0.00 | 0.00 | 172.4% -1.6 | 0 | 0 | 0 | 0.814 | -0.322 | 0.029 |
| put 2 Nov | OTM | 0.00 | 2.15 | 0.05 | 0.00 | 171.4% 0.0 | 2 | 0 | 0 | -0.187 | -0.307 | 0.029 | |
| call 1 Jan | 65.00 | ITM | 5.90 | 10.00 | 0.00 | 0.00 | 126.5% -1.8 | 0 | 0 | 0 | 0.759 | -0.276 | 0.033 |
| put 1 Jan | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 121.1% 0.0 | 0 | 0 | 0 | -0.242 | -0.241 | 0.035 | |
| call 8 Oct | 70.00 | ITM | 0.70 | 4.90 | 1.82 | 0.00 | 78.0% -2.6 | 2 | 0 | 0 | 0.656 | -0.206 | 0.039 |
| put 6 Nov | OTM | 0.00 | 2.15 | 0.05 | 0.00 | 80.2% +1.0 | 1 | 0 | 0 | -0.344 | -0.193 | 0.040 | |
| call 11 Nov | 75.00 | ATM | 0.00 | 0.05 | 0.05 | 0.00 | 12.9% -20.3 | 117 | 0 | 0 | 0.297 | -0.076 | 0.039 |
| put 5 Nov | ATM | 0.20 | 4.40 | 2.25 | 0.00 | 75.0% +39.6 | 2 | 0 | 0 | -0.698 | -0.078 | 0.037 | |
| call 27 Oct | 80.00 | OTM | 0.00 | 0.05 | 0.04 | 0.00 | 32.7% -0.8 | 1 | 0 | 0 | 0.038 | -0.018 | 0.009 |
| put | ITM | 5.10 | 9.40 | 7.10 | -0.20 | 114.0% +78.5 | 1 | 1 | 1 | -0.961 | -0.013 | 0.009 | |
| call 1 Jan | 85.00 | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 51.4% 0.0 | 0 | 0 | 0 | 0.024 | -0.020 | 0.006 |
| put 10 Nov | ITM | 10.10 | 14.40 | 12.30 | 0.00 | 145.6% +93.3 | 3 | 0 | 0 | -0.975 | -0.012 | 0.006 | |
| call 1 Jan | 90.00 | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 64.3% 0.0 | 0 | 0 | 0 | 0.019 | -0.020 | 0.005 |
| put 10 Nov | ITM | 15.60 | 19.40 | 17.30 | 0.00 | 172.8% +104.7 | 1 | 0 | 0 | -0.980 | -0.013 | 0.005 | |
| call 1 Jan | 95.00 | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 81.1% 0.0 | 0 | 0 | 0 | 0.016 | -0.022 | 0.004 |
| put 10 Nov | ITM | 20.10 | 24.40 | 22.30 | 0.00 | 196.9% +114.4 | 1 | 0 | 0 | -0.983 | -0.013 | 0.004 | |
| call 1 Jan | 100 | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 90.4% 0.0 | 0 | 0 | 0 | 0.014 | -0.021 | 0.004 |
| put 9 Nov | ITM | 25.60 | 29.40 | 27.10 | 0.00 | 218.8% +123.1 | 0 | 0 | 0 | -0.985 | -0.014 | 0.004 | |
| call 1 Jan | 105 | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 102.1% 0.0 | 0 | 0 | 0 | 0.013 | -0.022 | 0.004 |
| put 1 Jan | ITM | 30.10 | 34.40 | 0.00 | 0.00 | 234.9% +128.3 | 0 | 0 | 0 | -0.987 | -0.013 | 0.004 |
Latest SEC filings
30 of 702AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings
10-Q filed 2026-11-06, period ended 2026-09-30. 10-K filed 2026-08-24, period ended 2026-06-30. TECH on EDGAR
page 1 of 24Next →
| Filed | Form | Description | Period | Document |
|---|---|---|---|---|
| 2026-11-12 | 10-Q/A | All annual, quarterly, and current reports | 2026-09-30 | 0001104659-26-126284 index |
| 2026-11-06 | 10-Q | All annual, quarterly, and current reports | 2026-09-30 | 0001104659-26-123907 index |
| 2026-11-05 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0000315066-26-002681 index |
| 2026-11-04 | 8-K | All annual, quarterly, and current reports | 2026-11-03 | 0001104659-26-122283 index |
| 2026-11-03 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-01 · transaction | 0000914190-26-000175 index |
| 2026-11-03 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-01 · transaction | 0000914190-26-000174 index |
| 2026-11-02 | 4/A | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-15 · transaction | 0000914190-26-000171 index |
| 2026-11-02 | 4/A | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-15 · transaction | 0000914190-26-000170 index |
| 2026-11-02 | 4/A | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-15 · transaction | 0000914190-26-000169 index |
| 2026-11-02 | 4/A | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-15 · transaction | 0000914190-26-000167 index |
| 2026-11-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-29 · transaction | 0000914190-26-000162 index |
| 2026-11-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-29 · transaction | 0000914190-26-000161 index |
| 2026-11-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-29 · transaction | 0000914190-26-000160 index |
| 2026-11-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-29 · transaction | 0000914190-26-000159 index |
| 2026-11-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-29 · transaction | 0000914190-26-000158 index |
| 2026-11-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-29 · transaction | 0000914190-26-000157 index |
| 2026-11-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-29 · transaction | 0000914190-26-000156 index |
| 2026-11-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-29 · transaction | 0000914190-26-000155 index |
| 2026-10-28 | 10-K/A | All annual, quarterly, and current reports | 2026-06-30 | 0001140361-26-041062 index |
| 2026-09-30 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-28 · transaction | 0000914190-26-000142 index |
| 2026-09-24 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-22 · transaction | 0000914190-26-000139 index |
| 2026-09-23 | 8-K | All annual, quarterly, and current reports | 2026-09-23 | 0001140361-26-037450 index |
| 2026-09-14 | DEFA14A | Proxy materials | no report period | 0001140361-26-036500 index |
| 2026-09-14 | 8-K | All annual, quarterly, and current reports | 2026-09-14 | 0001140361-26-036499 index |
| 2026-09-09 | DEFA14A | Proxy materials | no report period | 0001140361-26-036072 index |
| 2026-09-02 | DEFA14A | Proxy materials | no report period | 0001140361-26-035490 index |
| 2026-08-25 | DEFA14A | Proxy materials | no report period | 0001140361-26-034325 index |
| 2026-08-24 | 10-K | All annual, quarterly, and current reports | 2026-06-30 | 0001104659-26-100322 index |
| 2026-08-20 | DEFM14A | Proxy materials | no report period | 0001140361-26-033911 index |
| 2026-08-19 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-17 · transaction | 0000914190-26-000134 index |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 320.39K | 1 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 116.79K | 1 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 8.96% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.53% |
| GOLDMAN SACHS GROUP INC | 4.69% |
| HBK INVESTMENTS L P | 4.36% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.16% |
| MORGAN STANLEY | 4.07% |
| FIL Ltd | 4.00% |
| STATE STREET CORP | 3.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 3.46% |
| Invesco Ltd. | 2.41% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Contrafund | 3.19% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 3.17% |
| VANGUARD 500 INDEX FUND | 2.59% |
| SMALLCAP World Fund Inc | 2.29% |
| VANGUARD SMALL-CAP INDEX FUND | 2.29% |
| Invesco S&P 500 Equal Weight ETF | 2.27% |
| Eaton Vance Atlanta Capital SMID-Cap Fund | 1.66% |
| VANGUARD EXPLORER FUND | 1.52% |
| iShares Core S&P 500 ETF | 1.38% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 1.32% |
OakChart. TECH. Cached 15 minutes. Terms